April 27, 2016
Bookmark and Share

WADA Publishes 2014 Anti-Doping Rule Violations Report

  • Report highlights 1,693 Anti-Doping Rule Violations (ADRVs) in 2014, involving individuals from 109 nationalities and across 83 sports
  • 1,462 ADRVs came from adverse analytical findings; 231 from ‘evidence-based intelligence’ non-analytical findings
  • 64% of the 2,287 AAFs reported in 2014 resulted in the 1,462 ADRVs
  • Of the 231 non-analytical ADRVs, 185 were committed by athletes and 46 by athlete support personnel
  • Figures are from the final year under the 2009 World Anti-Doping Code

The World Anti-Doping Agency (WADA) published its second annual Anti-Doping Rule Violations (ADRVs) Report today, which represents the most comprehensive set of global doping statistics in sport for 2014. 

The Report highlights that there was a total of 1,693 ADRVs recorded in 2014, involving individuals from 109 nationalities and across 83 sports. 1,462 of the ADRVs were derived from adverse analytical findings (AAFs); these 1,462 ADRVs represented 64% of the total 2,287 AAFs that were reported by WADA-accredited laboratories. The remaining 231 non-analytical ADRVs were issued as a result of evidence-based intelligence; of which, 185 were committed by athletes and 46 by athlete support personnel.

It is important to note that the 2014 ADRVs Report is based on violations that were committed and adjudicated pursuant to the 2009 World Anti-Doping Code (Code). Statistics related to violations committed and adjudicated pursuant to the 2015 Code will be released in 2017.

“The 2014 ADRVs Report makes for particularly interesting reading in combination with WADA’s 2014 Testing Figures Report that was published last July,” said WADA President, Sir Craig Reedie. “The 2014 Testing Figures Report highlighted the number of adverse analytical findings reported by WADA-accredited laboratories; whereas, the 2014 ADRVs Report confirms the number of those findings that resulted in sanctions,” he continued.  “The ADRVs Report released today represents the most comprehensive set of global doping statistics for sports and countries for 2014.”

“WADA looks forward to next year’s ADRVs Report; which, we believe, will reflect the impact of the new Code and the improved practice being carried out by the anti-doping community,” added Reedie.

“While many of the ADRVs resulted from analytical urine and blood testing, a notable number of ADRVs (231 in total) were declared for athletes and athlete support personnel that resulted from non-analytical means,” said WADA Director General, David Howman.  “These were determined through evidenced-based intelligence collected; such as evading, refusing or failing to submit a sample; possession and/or trafficking of a prohibited substance; or complicity, amongst other means,” Howman continued.  “This proves the increasing importance of non-analytical approaches to anti-doping, something which is now well emphasized under the revised World Anti-Doping Code,” he added.

“The Report also reminds us of the importance of values-based education to prevention and risk minimization,” said Howman.  “Such education programs enable two-way discussion with athletes on why doping is wrong, why it should not be done and how they can protect themselves against it.”

The ADRVs Report is broken down as follows:

  1. Executive Summary captures key figures and patterns of data contained in the Report.
  2. Sections 1 and 2 present the results management outcomes (including ADRVs) of all AAFs detected by WADA-accredited laboratories for samples collected from athletes in- and out-of-competition and received by the laboratories in 2014 by sport and discipline (Section 1) and testing authority (Section 2).
  3. Section 3 presents ADRVs that resulted from non-analytical findings by sport and nationality.   
  4. Section 4 presents the total number of ADRVs in 2014, which includes AAFs that resulted in an ADRV plus all non-analytical ADRVs; and, presents the data by sport and nationality. It is further broken down into type of samples (urine or blood), type of test (in- or out-of-competition) and athlete gender.  

Please click here to download the full Report, a Backgrounder and Frequently-Asked Questions.

-30-

For more information, please contact:

Ben Nichols, Senior Manager, Media Relations and Communications

Phone: + 1-514-904-8820
Cell: + 1-514-979-8820
E-mail: ben.nichols@wada-ama.org